Metabolic Signatures of Vertigo: A qNMR Exploration Into the Biochemical Landscape
NMR in Biomedicine · 2026-07 · 39 (7)
DOI: 10.1002/nbm.70319 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 25.05.2026. Verfasst von Muhammed Parlak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, Bezmialem Vakif University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Vertigo, Metabolome, Metabolomics. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Vertigo is a type of dizziness that typically occurs without movement and may arise independently or as a symptom of an underlying condition. It is classified as either central or peripheral, with central vertigo often caused by brain tumors, hemorrhages, or vascular aneurysms. This study aims to identify functional metabolites associated with vertigo and explore their related metabolic pathways. Metabolic profiling of serum samples from 33 vertigo patients and 34 healthy controls was conducted using 1 H‐QNMR spectroscopy. Following log 10 transformation and normalization, univariate and multivariate analyses (FC, p ‐value, FDR, and VIP) were applied to identify significant metabolites. KEGG‐based pathway and disease enrichment analyses were performed to explore biological relevance and clinical associations. ROC analysis was performed to evaluate the ability of selected metabolites to discriminate between vertigo patients and healthy controls within this exploratory dataset, and inter‐metabolite relationships were assessed using Pearson correlation. Vertigo patients showed significantly different metabolomic profiles compared to healthy controls. Serum levels of capric acid, homocysteine, O‐phosphoethanolamine, methylmalonate, N‐carbamoylaspartate, and proline were significantly elevated, while glycylproline levels were decreased. These findings suggest a potential link between vertigo and these functionally relevant metabolites. Vertigo patients showed lower glycylproline and higher homocysteine and capric acid levels than healthy controls. These metabolites discriminated between groups in this exploratory cohort, but they should not be interpreted as clinically validated diagnostic markers. Further independent, longitudinal, and clinically well‐characterized studies are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, School of Medicine, Bezmialem Vakif University, Istanbul, Türkiye.
- Bezmialem Vakif University, Istanbul, Türkiye.
- Department of Emergency Medicine, School of Medicine, Bezmialem Vakif University, Istanbul, Türkiye.
- Biochemistry Public Health Laboratory, Siirt, Türkiye.
ORCID-Profile: Muhammed Parlak, Şahabettin Selek, Yasin Arifoğlu, Metin Demirel, Sedat Meydan
Zitieren
APA
Parlak, M., Selek, Ş., Arifoğlu, Y., Metin, H., Yıldız, T., Demirel, M., & Meydan, S. (2026). Metabolic Signatures of Vertigo: A qNMR Exploration Into the Biochemical Landscape. NMR in Biomedicine, 39(7). https://doi.org/10.1002/nbm.70319
Vancouver
Parlak M, Selek Ş, Arifoğlu Y, Metin H, Yıldız T, Demirel M, et al. Metabolic Signatures of Vertigo: A qNMR Exploration Into the Biochemical Landscape. NMR in Biomedicine. 2026;39(7). doi:10.1002/nbm.70319
BibTeX
@article{Parlak2026,
author = {Parlak, Muhammed and Selek, Şahabettin and Arifoğlu, Yasin and Metin, Hüseyin and Yıldız, Tuğçe and Demirel, Metin and Meydan, Sedat},
title = {Metabolic Signatures of Vertigo: A qNMR Exploration Into the Biochemical Landscape},
journal = {NMR in Biomedicine},
year = {2026},
volume = {39},
number = {7},
doi = {10.1002/nbm.70319}
}
EUVIMED